38.43

1.69% -0.66

After Hours: 38.39 -0.04 -0.10%

Claritev Corp (CTEV)

Overview News Price History Discussions Forecast

Claritev Corp stock is traded at $38.43, with a volume of 70,564. It is down -1.69% in the last 24 hours and up +45.57% over the past month. Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The company's focus is on being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.

Previous Close:

$39.09

Open:

$39.08

24h Volume:

70,564

Relative Volume:

0.56

Market Cap:

$651.29M

Revenue:

$978.76M

Net Income/Loss:

$-286.52M

P/E Ratio:

-2.2187

EPS:

-17.3212

Net Cash Flow:

$-31.63M

1W Performance:

-2.44%

1M Performance:

+45.57%

6M Performance:

+115.66%

1Y Performance:

-43.20%

1-Day Range:

$37.66

$39.08

1-Week Range:

$36.99

$42.00

52-Week Range:

$11.50

$74.07

Claritev Corp Stock (CTEV) Company Profile

Name

Claritev Corp

Sector

Healthcare (1074)

Industry

Health Information Services (47)

Phone

212-780-2000

Address

7900 TYSONS ONE PLACE, MCLEAN

Employee

3,000

Twitter

Next Earnings Date

2026-08-07

Latest SEC Filings

CTEV's Discussions on Twitter

Compare CTEV vs VEEV, BTSG, TEM, TXG, HQY

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CTEV Claritev Corp	38.43	577.57M	978.76M	-286.52M	-31.63M	-17.32
VEEV Veeva Systems Inc	275.09	40.70B	3.32B	941.65M	1.64B	5.6161
BTSG Brightspring Health Services Inc	60.73	11.78B	13.65B	169.86M	412.12M	1.0758
TEM Tempus Ai Inc	64.62	12.03B	1.36B	-302.91M	-219.93M	-1.7182
TXG 10 X Genomics Inc	62.65	8.32B	638.78M	-22.66M	122.18M	-0.1744
HQY Healthequity Inc	96.07	8.72B	1.34B	230.70M	440.96M	2.6695

Claritev Corp Stock (CTEV) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-24-26	Initiated	Barclays	Overweight
Jan-12-26	Initiated	Guggenheim	Buy
Jan-09-26	Initiated	Wells Fargo	Equal Weight
Oct-21-25	Upgrade	Citigroup	Neutral → Buy
May-29-25	Upgrade	Piper Sandler	Neutral → Overweight
Jun-26-24	Initiated	Piper Sandler	Neutral
Dec-13-22	Downgrade	Citigroup	Buy → Neutral
Jul-12-22	Initiated	Goldman	Neutral
Oct-04-21	Resumed	Citigroup	Buy
Apr-07-21	Initiated	B. Riley Securities	Buy
Mar-19-21	Initiated	Barclays	Equal Weight

View All

Claritev Corp Stock (CTEV) Latest News

Aug 21, 2026

Claritev Chief Growth Officer Tiffani Misencik sells 8,850 shares worth $354,592.95 - Bitget

Aug 18, 2026

Aug 17, 2026

Claritev says Marpai expands contract for pre- and post-payment claims integrity services - Bitget

Aug 17, 2026

CTEV Looks 33.2% Overvalued on GF Value™ - GuruFocus

Aug 17, 2026

Marpai expands Claritev agreement for payment integrity By Investing.com - Investing.com Australia

Aug 17, 2026

Marpai expands Claritev agreement for payment integrity - Investing.com

Aug 17, 2026

Marpai expands beyond network access—but what comes next? - Stock Titan

Aug 17, 2026

Marpai Expands Relationship With Claritev To Help Reduce Healthcare Costs For Employer Clients - TradingView

Aug 17, 2026

Marpai Expands Relationship with Claritev to Help Reduce Healthcare Costs for Employer Clients - Business Wire

Aug 17, 2026

Claritev (CTEV) Institutional Ownership 2026 - MarketBeat

Aug 17, 2026

Aug 16, 2026

Claritev $CTEV Shares Sold by Renaissance Technologies LLC - MarketBeat

Aug 16, 2026

Aug 15, 2026

Claritev (NYSE:CTEV) Rating Increased to Hold at Zacks Research - MarketBeat

Aug 15, 2026

Aug 14, 2026

Claritev Corp SEC Filing (Aug 14, 2026) - Stock Titan

Aug 14, 2026

Claritev (NYSE:CTEV) Shares Down 5.1%Time to Sell? - MarketBeat

Aug 14, 2026

Have Insiders Sold Claritev Shares Recently? - simplywall.st

Aug 14, 2026

CTEV|Claritev Corp|Price:35.100|Chg%:+1.020 - TradingKey

Aug 14, 2026

Aug 13, 2026

Claritev (CTEV) Stock Fair Value Rises After Analysts Weigh Growth Against Leverage Risks - Yahoo Finance

Aug 13, 2026

Claritev (NYSE:CTEV) Stock Price Up 7.7% Following Analyst Upgrade - MarketBeat

Aug 13, 2026

Aug 12, 2026

Arini Capital Management Ltd's Claritev Corp(CTEV) Holding History - GuruFocus

Aug 12, 2026

Claritev Corp SVP William B. Mintz Sells 8,431 Shares of Class A Stock at $34.24 Each - Kalkine Media

Aug 12, 2026

Insider Selling: Claritev (NYSE:CTEV) SVP Sells 8,431 Shares of Stock - MarketBeat

Aug 12, 2026

Claritev Insider Sold Shares Worth $288,677, According to a Recent SEC Filing - marketscreener.com

Aug 12, 2026